This study utilized a tumor model induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in male BC mice, and 93 tumor tissue specimens from BC patients undergoing surgical treatment were analyzed for correlations between CD276 expression and patient survival [77]. This evidence concerns the gene CD276 and breast cancer.